4[1]BeckerRC,TracyRP,BovillEG,et al.The clinicaluse flow cytometry for assessing platelet activation in acute cornary syndromes TIMI-ⅢThrombosis and AnticoagulatiGroup[J].Coron Artery Dis,1994,5(4):339-345. 被引量:1
5[4]Osamah H Llbr Jclin[J].Pharmcol,1997,44(1):77. 被引量:1
6[5]Kuzuya T,Kamura Y,Hoshida S,et al.The effect of CV-4151,a selective inhibitor of thromboxame synthestase,on prostanoid formation and platelet aggregation in human[J].Cardiovase Drugs Ther,1988,2(5):693-700. 被引量:1
7[10]McEverR P,MartinM N.A monoclonal antibody to a membrance glycoproteinbinds only to activated platelets.JBiolChem,1984,259(15):799-804. 被引量:1
8[11]CARTER A M,ANAGNOSTOPOULOU K,MANSFIELD M W,et al.Soluble P-selectin levels,P-selectipolymor-phisms and cardiovascular disease[J].J ThromHaemost,2003,1:1718-1723. 被引量:1
9[12]SHEBUSKI R J,KILGORE K S.Role of inflammatory mediators in thrombogenesis[J].J Pharmacol Exp Ther,2002,300:729-735. 被引量:1
10[14]SpringerTA,LaskyLA.Cell adhesion[J].Sticky sugars for selectins.Nature,1991,349 (6306):196-197. 被引量:1